레이크쇼어 바이오파마 (LSBCF) 주가

레이크쇼어 바이오파마(LSBCF)는 NYSE에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.07 (+0.00%), 시가총액 $0.00B, 52주 범위 $0.03 ~ $1.38.

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic

핵심 지표

• 현재가: $0.07 (+0.00%)
• 시가총액: $0.00B
• 52주 최저~최고: $0.03 ~ $1.38
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NYSE

레이크쇼어 바이오파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

레이크쇼어 바이오파마 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.03
• 순이익률: -0.16%
• 영업이익률: -0.69%

자주 묻는 질문